*|MC:SUBJECT|*
BioRN News November 2022
View this email in your browser

Dear *|FNAME|* *|LNAME|*,


while last weeks of this 2022 are rolling out, conferences, round table discussions, visits and workshops are at full speed.
BioRN maintains a constant exchange with regional politicians to inform about trends and developments within the cluster. The green politician Norbert Knopf (MdL) discussed with us about the needs of a life science for constant growth and development [more].

Julia Schaft, BioRN Managing Director joined a very distinct and forward thinking panel on "Future Work: The role of shared laboratories and incubators" at the Future Medicine Science Match in Berlin, organised and moderated by Johannes Fruehauf from BioLabs. One of the key-messages: Public Private Partnerships are a great option for Universities to open themselves up more for early cooperation with industry [more]
At the Annual Meeting of the Forum Gesundheitsstandort Baden-Württemberg, we actively contributed in the discussion around data access for industry and harmonisation and standardisation of data collection
[more].

And before the holidays we have still some events coming up: BioRN Lounge, BioRN espresso, General Assembly, ... more information here in our Newsletter!
 
Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
01 | Research Highlights & News
02 | New Members
03 | Events Spotlight
04 | Event Calendar & Discounts
05 | Open Positions
Hot from the Press
01| Research Highlights & News

Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE®) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101 [more]

Accelerating innovation: BIO Deutschland publishes a "Licensing Guide" [more]

Three EIT Health's Catapult-supported start-ups will recieve EIC grants [more]

Several prestigious ERC Grants awarded to scientists in the region [more] and [more]

EMBL & DKFZ: New Molecular Microscopy Uncovers how Breast Cancer Spreads [more]

Fraunhofer IGB: Therapeutic viruses against tumours and metastases [more]

Heidelberg Pharma`s Partner Telix Reports Positive Data on the Pivotal ZIRCON Study [more]

Heidelberg University 
  • Second Stem Cell Type Discovered in Mouse Brain [more]
  • FundaMental Pharma launches with EUR 10 million in Seed financing led by BGV and Thuja Capital to advance a First-in-Class neuroprotectant [more]
  • Heidelberg University with 13 “Highly Cited Researchers" [more]
  • Number One in Germany in the Life Sciences [more]

Scientists at Heidelberg University Hospital, DKFZ and HI-STEM have discovered a new mechanism for the self-renewal of leukemia stem cells [more]

Novaliq announces FDA acceptance of the new drug application for CyclaSol® for the treatment of dry eye disease [more]

Innovation challenges and awards:
  • Merck KGaA Darmstadt Germany Innovation Cup 2023 [more]
  • Apply until 4th December to the NEC Innovation Challenge! [more]
  • Apply for Sanofi iDEA-iTECH Awards [more] 

02 | New Members


faCellitate is a high interdisciplinary SME, with a strong focus on R&D and rich technical and entrepreneurial experience. faCellitate develops polymer surface coating for plastic and glassware which are applicable for cell-based assays in the context of cancer and stem cell research, drug development and toxicological studies.
faCellitate is a spin-out of Chemovator GmbH (and thus of BASF SE) and raised successfully 3.7 million Euro in its closing funding in 2022.

PL BioScience are experts in cell culture supplements derived from human platelets. PL BioScience's mission is to enhance the advances in cellular research and therapy with one forward-looking Technology: ELAREM TM.
PL BioScience is a biotech company was founded in 2015 as an RTWH Aachen University spin-off.

03 | Events Spotlight

04 | Event Calendar & Discounts


Virtual Roadshow: AI in Health Care and Medical Technologies 
December 1, 2022 - Online >>
 
4C Close up – Insights into C2 | How to just do QMS
December 5, 2022 - Online >>

 
10th European Data Protection SUMMIT Applied To Health Data
December 7, 2022 - Brussels, Belgium >>

 
The Spectra Of Life: Dimensional Breadth In Biological Research
EMBL PhD Symposium
December 7-9, 2022 - Heidelberg >>

 
WEB | Goods & Services Tax (GST) in Australien, einfach erklärt!
December 8, 2022 - Online >>
 
Clinical Trial Masterclass
December 8, 2022 - Online >>
 
Better Together: Managing Term Sheets for a Successful Collaboration
December 8, 2022 - Online & Amsterdam >>
 
Online-Informationsveranstaltung zu Ausschreibungsthemen von Digitalisierung, Industrie und Gesundheit in Horizont Europa
December 9, 2022 - Online >>
 

From Discovery to Market Readiness, a CTDMO as an Enabler
December 13, 2022 - Online >>
 

Meet & Match Cell and Gene Therapy
December 14, 2022 - Online >>
 
German Pavilion @ BIO Convention
Join the German Pavillon in the exhibition hall at reduced fees.
Application Deadline: January 31, 2023
June 5-8, 2023 - Boston, USA >>

 

05 | Open Positions


Affimed: Clinical Biomarker Lead/Translational Project Lead (f/m/d) [more]

Apogenix: Manager Quality Assurance / Quality Management (m/w/d) [more]

Ardigen S.A.:
Business Development Manager DACH [more]

PEPperPRINT: Biologielaborant/in, BTA, MTA (m/w/d) [more]

PROGEN:
Mitarbeiter/in in der Qualitätskontrolle (m/w/d) [more]

ValueData GmbH: Consultant Künstliche Intelligenz [more]

VERAXA Biotech GmH: Scientist ADC Chemistry [more]
We have partnered with ProcEurope!
What are the benefits for BioRN Members?
  • Significant discounts with Fisher Scientific, an average 44% off list price as well as no delivery, dry ice, hazardous or minimum order charges. 
  • New Suppliers reviewed and brought on board on a regular bases. 
  • No change to processes! ProcEurope negotiate the pricing, but the ordering method stays the same, you order directly with the supplier and liaise with the same sales representative as before.
  • No need to pay ProcEurope's €250 annual fee.

Find out more >>                                                                                      Download
Tweet
Forward
Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Dr. Annalisa Zuccotti

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*